Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Market Access & Health Policy Année : 2019

Dates et versions

hal-02271194 , version 1 (26-08-2019)

Identifiants

Citer

Pierre Lévy, David M. Smadja, Julie Dorey, Mondher Toumi, Anna-Katharina Meinecke, et al.. Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective. Journal of Market Access & Health Policy, 2019, 7 (1), ⟨10.1080/20016689.2018.1564506⟩. ⟨hal-02271194⟩
37 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More